Catalyst Pharmaceutical Partners Inc buy StockNews.com
Start price
25.12.24
/
50%
€20.76
Target price
25.12.25
-
Performance (%)
-18.16%
Price
22.09.25
€16.99
Summary
This prediction is currently active. The prediction for Catalyst Pharmaceutical Partners Inc disappoints with a performance of -18.16%. This prediction currently runs until 25.12.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 1.161% | 1.161% |
| iShares Core DAX® | -0.560% | -3.108% |
| iShares Nasdaq 100 | 1.622% | 4.701% |
| iShares Nikkei 225® | 1.807% | 5.094% |
| iShares S&P 500 | 0.859% | 2.906% |
Comments by StockNews_com for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by StockNews_com for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€16.81
21.09.25
21.09.25
-
21.09.26
21.09.26
1.10%
22.09.25
22.09.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€21.73
11.01.25
11.01.25
-
11.01.26
11.01.26
-21.81%
22.09.25
22.09.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.62
04.01.25
04.01.25
-
04.01.26
04.01.26
-17.60%
22.09.25
22.09.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.43
08.06.24
08.06.24
-
08.06.25
08.06.25
59.39%
09.06.25
09.06.25